ONCTERNAL THERAPEUTICS INC (ONCT)

US68236P2065 - Common Stock

8.29  +0.04 (+0.48%)

After market: 9.36 +1.07 (+12.91%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
785.00K1.49M4.32M3.38M2.43M
Operating Expenses
42.50M46.44M35.68M20.92M35.53M
Research and Development
29.75M32.98M24.09M12.54M28.25M
Selling, General, and Administrative Expenses
12.75M13.46M11.60M8.37M7.29M
Operating Income
-41.71M-44.95M-31.37M-17.54M-33.11M
Interest Income/Expense
2.23M780.00K30.00K20.00K190.00K
Other Income/Expense
N/AN/A0.00300.00K-1.27M
Income Before Taxes
-39.48M-44.17M-31.33M-17.23M-34.19M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-39.48M-44.17M-31.33M-17.23M-34.19M
EBITDA
N/AN/AN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-13.43-0.84-0.64-0.85-3.31
Non GAAP EPS
-13.51-4.64-0.63N/AN/A
 
Statistics
Profit Margin
-5029.17%-2964.43%-725.23%-509.76%-1407.00%
Operating Profit Margin
-5313.89%-3016.78%-726.16%-518.93%-1362.55%

All data in USD

Charts